XML 67 R38.htm IDEA: XBRL DOCUMENT
v2.4.1.9

INTANGIBLE ASSETS (Details ) (USD $) | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2015 | Dec. 31, 2014
Finite-Lived Intangible Assets |  |
Accumulated Amortization | $ (120,331)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization | $ (113,640)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
Indefinite-Lived Intangible Assets |  |
Gross Carrying Amount | 1,379,081 us-gaap_IntangibleAssetsGrossExcludingGoodwill | 1,342,228 us-gaap_IntangibleAssetsGrossExcludingGoodwill
Net Amount | 1,258,750 us-gaap_IntangibleAssetsNetExcludingGoodwill | 1,228,588 us-gaap_IntangibleAssetsNetExcludingGoodwill
Hormone therapy drug candidate patents - Pending [Member] |  |
Indefinite-Lived Intangible Assets |  |
Gross Carrying Amount | 691,465 us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_HormoneTherapyDrugCandidatePatentsMember | 675,982 us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_HormoneTherapyDrugCandidatePatentsMember
Net Amount | 691,465 txmd_IndefiniteLivedIntangibleAssetsExcludingGoodwillNet / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_HormoneTherapyDrugCandidatePatentsMember | 675,982 txmd_IndefiniteLivedIntangibleAssetsExcludingGoodwillNet / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_HormoneTherapyDrugCandidatePatentsMember
Multiple trademarks for vitamins/supplements [Member] |  |
Indefinite-Lived Intangible Assets |  |
Gross Carrying Amount | 124,738 us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_MultipleTrademarksForVitaminsSupplementsMember | 103,368 us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_MultipleTrademarksForVitaminsSupplementsMember
Net Amount | 124,738 txmd_IndefiniteLivedIntangibleAssetsExcludingGoodwillNet / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_MultipleTrademarksForVitaminsSupplementsMember | 103,368 txmd_IndefiniteLivedIntangibleAssetsExcludingGoodwillNet / us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis = txmd_MultipleTrademarksForVitaminsSupplementsMember
OPERA software patent [Member] |  |
Finite-Lived Intangible Assets |  |
Gross Carrying Amount | 31,951 us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_ComputerSoftwareIntangibleAssetMember | 31,951 us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_ComputerSoftwareIntangibleAssetMember
Accumulated Amortization | (2,995)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_ComputerSoftwareIntangibleAssetMember | (2,496)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_ComputerSoftwareIntangibleAssetMember
Net Amount | 28,956 us-gaap_FiniteLivedIntangibleAssetsNet / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_ComputerSoftwareIntangibleAssetMember | 29,455 us-gaap_FiniteLivedIntangibleAssetsNet / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_ComputerSoftwareIntangibleAssetMember
Weighted Average Amortization Period | 14 years 6 months | 14 years 9 months
Development costs for corporate website [Member] |  |
Finite-Lived Intangible Assets |  |
Gross Carrying Amount | 91,743 us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_InternetDomainNamesMember | 91,743 us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_InternetDomainNamesMember
Accumulated Amortization | (91,743)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_InternetDomainNamesMember | (91,743)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = us-gaap_InternetDomainNamesMember
Net Amount |  |
Approved Hormone Therapy Drug Candidate Patents [Member] |  |
Finite-Lived Intangible Assets |  |
Gross Carrying Amount | 439,184 us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = txmd_ApprovedHormoneTherapyDrugCandidatePatentsMember | 439,184 us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = txmd_ApprovedHormoneTherapyDrugCandidatePatentsMember
Accumulated Amortization | (25,593)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = txmd_ApprovedHormoneTherapyDrugCandidatePatentsMember | (19,401)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = txmd_ApprovedHormoneTherapyDrugCandidatePatentsMember
Net Amount | $ 413,591 us-gaap_FiniteLivedIntangibleAssetsNet / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = txmd_ApprovedHormoneTherapyDrugCandidatePatentsMember | $ 419,783 us-gaap_FiniteLivedIntangibleAssetsNet / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = txmd_ApprovedHormoneTherapyDrugCandidatePatentsMember
Weighted Average Amortization Period |  | 18 years
Non-Amortizing Intangible Assets [Member] |  |
Finite-Lived Intangible Assets |  |
Weighted Average Amortization Period | 17 years 9 months |

X
- Definition Net amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit. + References No definition available. + Details
Name: | txmd_IndefiniteLivedIntangibleAssetsExcludingGoodwillNet
Namespace Prefix: | txmd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275 + Details
Name: | us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsNetAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 + Details
Name: | us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount before accumulated amortization of intangible assets, excluding goodwill. + References No definition available. + Details
Name: | us-gaap_IntangibleAssetsGrossExcludingGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph ((a)(1),(b)) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 + Details
Name: | us-gaap_IntangibleAssetsNetExcludingGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=txmd_ApprovedHormoneTherapyDrugCandidatePatentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=txmd_NonAmortizingIntangibleAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InternetDomainNamesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=txmd_HormoneTherapyDrugCandidatePatentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=txmd_MultipleTrademarksForVitaminsSupplementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |